New Depixus job opening in Cambridge (UK)!

Read More

Depixus today opened a new job position! For more details, please visit the Job descriptions

New Depixus job opening in Paris (FR)!

Read More

Depixus today opened a new job position! For more details, please visit the Job descriptions

New Depixus job opening in Cambridge (UK)!

Read More

Depixus today opened a new job position! For more details, please visit the Job descriptions

New Depixus job opening!

Read More

Depixus today opened a new job position! For more details, please visit the Job descriptions

New Depixus job opening!

Read More

Depixus today opened a new job position! For more details, please visit the Job descriptions

New Depixus job opening!

Read More

Depixus today opened a new job position! For more details, please visit the Job descriptions

New Depixus job opening!

Read More

Depixus today opened a new job position! For more details, please visit the Job descriptions

PicoSeq announces corporate name change to Depixus

Read More

PicoSeq announced today that it is changing its corporate name to Depixus. “The name change reflects the company’s breadth of interest across both genetic and epigenetic analysis, with our technology being developed for applications far beyond just DNA sequencing” said Gordon Hamilton, Depixus’ Président (CEO). The new name is effective immediately and will be implemented across the company over…

PicoSeq opens new offices and labs in both France and the UK

Read More

PicoSeq have moved their Paris labs and offices to a new location: 3-5 Impasse Reille in the 14th Arrondissement and have also opened a new R&D base near Cambridge, UK. “These new facilities will allow us to significantly expand our team and the scope of our R&D activities” commented CEO Gordon Hamilton. Contact details for our French and UK R&D sites can be found here.  

PicoSeq chosen for 2nd stage of French world innovation challenge program.

Read More

©présidence de la République/M.ETCHEGOYEN PicoSeq has been selected as one of 16 companies to receive a grant in the second phase of the Concours Mondial de l’Innovation (Worldwide Innovation Challenge). At an award ceremony at the Elysee Palace today, PicoSeq was one of just 3 companies to receive the award in the field of ‘Personalised Medicine’ (one of the 7 categories in the challenge). The…